tradingkey.logo
tradingkey.logo
Buscar

Evotec SE

EVO
Añadir a la lista de seguimiento
2.900USD
+0.050+1.75%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
1.03BCap. mercado
PérdidaP/E TTM

Más Datos de Evotec SE Compañía

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Información de Evotec SE

Símbolo de cotizaciónEVO
Nombre de la empresaEvotec SE
Fecha de salida a bolsaOct 11, 1999
Director ejecutivoWojczewski (Christian)
Número de empleados4827
Tipo de seguridadDepository Receipt
Fin del año fiscalOct 11
DirecciónEssener Bogen 7
CiudadHAMBURG
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal22419
Teléfono4940560810
Sitio Webhttps://www.evotec.com/
Símbolo de cotizaciónEVO
Fecha de salida a bolsaOct 11, 1999
Director ejecutivoWojczewski (Christian)

Ejecutivos de Evotec SE

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Evotec SE?

Los cinco principales accionistas de Evotec SE son: Dr. Cord Dohrmann, Ph.D.

¿Cuántas instituciones poseen acciones de Evotec SE (EVO)?

A fecha de 2026Q1, 81 instituciones poseen acciones de Evotec SE, con un valor de mercado combinado de aproximadamente 9.58M, lo que representa el 2.69% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -584606.00.